Apixaban Compared With Warfarin for Stroke Prevention in Atrial Fibrillation Implications of Time in Therapeutic Range

被引：11
|
作者：
Gallego, Pilar [1 ,2 ]
Antonio Vilchez, Juan [1 ,3 ,4 ]
Lane, Deirdre A. [1 ]
机构：
[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Morales Meseguer Univ Hosp, Dept Hematol & Clin Oncol, Murcia, Spain
[3] Hosp Univ Virgen de la Arrixaca, Dept Cardiol, Murcia, Spain
[4] Hosp Univ Virgen de la Arrixaca, Dept Clin Anal, Murcia, Spain
来源：
CIRCULATION | 2013年 / 127卷 / 22期
关键词：
Editorials; anticoagulants; apixaban; atrial fibrillation; time in therapeutic range; warfarin; NORMALIZED RATIO CONTROL; ANTICOAGULATION CONTROL; ORAL ANTICOAGULANT; EFFICACY; OUTCOMES; QUALITY; SAFETY;
D O I：
10.1161/CIRCULATIONAHA.113.003132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2163 / 2165
页数：3
相关论文
共 50 条
  • [21] Is Dabigatran Cost Effective Compared With Warfarin for Stroke Prevention in Atrial Fibrillation? A Critically Appraised Topic
    Adcock, Amelia K.
    Lee-Iannotti, Joyce K.
    Aguilar, Maria I.
    Hoffman-Snyder, Charlene R.
    Wingerchuk, Dean M.
    Wellik, Kay E.
    Demaerschalk, Bart M.
    NEUROLOGIST, 2012, 18 (02) : 102 - 107
  • [22] Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
    Sjalander, Sara
    Sjogren, Vilhelm
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    THROMBOSIS RESEARCH, 2018, 167 : 113 - 118
  • [23] Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective
    Kostas Athanasakis
    Nadia Boubouchairopoulou
    Eleftheria Karampli
    Filippos Tarantilis
    Paraskevi Savvari
    Aikaterini Bilitou
    John Kyriopoulos
    American Journal of Cardiovascular Drugs, 2017, 17 : 123 - 133
  • [24] Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
    Healey, Jeff S.
    Lopes, Renato D.
    Granger, Christopher B.
    Alings, Marco
    Rivard, Lena
    McIntyre, William F.
    Atar, Dan
    Birnie, David H.
    Boriani, Giuseppe
    Camm, A. John
    Conen, David
    Erath, Julia W.
    Gold, Michael R.
    Hohnloser, Stefan H.
    Ip, John
    Kautzner, Josef
    Kutyifa, Valentina
    Linde, Cecilia
    Mabo, Philippe
    Mairesse, Georges
    Benezet Mazuecos, Juan
    Cosedis Nielsen, Jens
    Philippon, Francois
    Proietti, Marco
    Sticherling, Christian
    Wong, Jorge A.
    Wright, David J.
    Zarraga, Ignatius G.
    Coutts, Shelagh B.
    Kaplan, Andrew
    Pombo, Marta
    Ayala-Paredes, Felix
    Xu, Lizhen
    Simek, Kim
    Nevills, Sandra
    Mian, Rajibul
    Connolly, Stuart J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (02) : 107 - 117
  • [25] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in Chinese patients with atrial fibrillation
    Mao, Lizheng
    Li, Chengyan
    Li, Tao
    Yuan, Kunxiong
    VASCULAR, 2014, 22 (04) : 252 - 258
  • [26] Patients' time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic
    Lee, Siew Ling
    Ong, Thien Jian
    Mazlan-Kepli, Wardati
    Mageswaran, Annuysia
    Tan, Kai Hsin
    Abd-Malek, Abdul-Muizz
    Cronshaw, Robert
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (09): : 483 - 492
  • [27] Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
    Szummer, Karolina
    Gasparini, Alessandro
    Eliasson, Staffan
    Arnlov, Johan
    Qureshi, Abdul Rashid
    Barany, Peter
    Evans, Marie
    Friberg, Leif
    Carrero, Juan Jesus
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (03):
  • [28] Atrial fibrillation and stroke prevention: is warfarin still an option?—No
    R. Lakshmi Narasimhan Ranganathan
    P. Venkatesh
    Journal of Neural Transmission, 2013, 120 : 1453 - 1456
  • [29] Atrial fibrillation and stroke prevention: is warfarin still an option?-No
    Ranganathan, R. Lakshmi Narasimhan
    Venkatesh, P.
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (10) : 1453 - 1456
  • [30] Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation
    Williams, Brent A.
    Evans, Michael A.
    Honushefsky, Ashley M.
    Berger, Peter B.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (10):
12345